NCT05099614View on ClinicalTrials.gov

Naloxone Auto-injection in Healthy Volunteers

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 10, 2021

Primary Completion Date

April 5, 2021

Study Completion Date

April 5, 2021

Conditions
Overdose Antidote
Interventions
COMBINATION_PRODUCT

Naloxone hydrochloride injection solution, SmartDose wearable auto injector and mobile respiratory sensing system

1.2 mg of naloxone hydrochloride is administered to healthy adults using the SmartDose wearable auto injector and the mobile respiratory sensing system.

Trial Locations (1)

98195

University of Washington, Seattle

All Listed Sponsors
collaborator

U.S. National Science Foundation

FED

lead

University of Washington

OTHER

NCT05099614 - Naloxone Auto-injection in Healthy Volunteers | Biotech Hunter | Biotech Hunter